Dr. Prathab Devaraj, MD

Dr. Devaraj practices at Banner Gateway Medical Center in Gilbert, Arizona, part of Banner Health.

Dr. Devaraj's NPI, 1073778064, was assigned on July 19, 2008. Dr. Devaraj holds Arizona license 46888.

Dr. Devaraj's primary practice is Banner Gateway Medical Center, at 1900 North Higley Road, Gilbert, AZ 85234 in Maricopa County. The practice phone is (480) 543-2000.

Dr. Devaraj's primary practice is Banner Gateway Medical Center in Gilbert, Arizona, part of Banner Health. Dr. Devaraj is also affiliated with Banner Desert Medical Center. The medical group on file is Banner Medical Group. Dmand AI also links Dr. Devaraj to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Devaraj practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Devaraj's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Devaraj is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Devaraj's licenses on file in 2 states: Arizona and Pennsylvania.

CMS data shows 581 Medicare services from Dr. Devaraj across 18 procedure codes in 2024, for 292 Medicare patients. Medicare paid $58,071 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 292 Medicare patients who saw Dr. Devaraj in 2024. The largest group is 65 to 74, with 161 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Devaraj's median patient age at 64, with 50% women.

In 2024, Dr. Devaraj wrote 298 Medicare Part D claims for 220 patients. 86% of them were for generic drugs. CMS names the drug for 253 of them, across 6 drugs with 11 or more claims each, at $7,739 in total drug cost. In 2023, CMS named 226 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Devaraj for performance year 2024, reported as part of a group. Dr. Devaraj accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Devaraj as offering telehealth. CMS counts 419 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Devaraj, more than 98% of the clinicians it reports for that procedure.

CMS Open Payments shows 81 general payments to Dr. Devaraj from 19 drug and device companies from 2016 to 2025. Travel and lodging make up the largest share, 65% of the total. Boston Scientific Corporation paid the most, $2,774.